DNA Vaccines

Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.

Also Known As:

Vaccines, DNA; DNA Vaccine, Naked; DNA Vaccine, Recombinant; DNA Vaccines, Naked; DNA Vaccines, Recombinant; Vaccine, DNA; Vaccine, Naked DNA; Vaccine, Recombinant DNA; Vaccines, Naked DNA; DNA Vaccine; Naked DNA Vaccine; Naked DNA Vaccines; Recombinant DNA Vaccine; Recombinant DNA Vaccines; Vaccines, Recombinant DNA

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Recombinant Proteins: 2811
    - Synthetic Vaccines: 1084
      - Nucleic Acid-Based Vaccines: 116
        DNA Vaccines: 2707
Complex Mixtures: 1947
- Biological Products
  - Vaccines: 128365
    - Synthetic Vaccines: 1084
      - Nucleic Acid-Based Vaccines: 116
        DNA Vaccines: 2707
Biological Factors: 2560
- Antigens: 145631
  - Synthetic Vaccines: 1084
    - Nucleic Acid-Based Vaccines: 116
      - DNA Vaccines: 2707

WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine Selected Research

WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine Research Topics

Disease

Drug/Important Bio-Agent (IBA)